These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 2427294

  • 1. [The ADP-ribosylation site and RNA-binding center are located in different regions of the elongation factor EF-2].
    Davydova EK.
    Dokl Akad Nauk SSSR; 1986; 289(2):510-2. PubMed ID: 2427294
    [No Abstract] [Full Text] [Related]

  • 2. Eukaryotic elongation factor 2 loses its non-specific affinity for RNA and leaves polyribosomes as a result of ADP-ribosylation.
    Sitikov AS, Davydova EK, Bezlepkina TA, Ovchinnikov LP, Spirin AS.
    FEBS Lett; 1984 Oct 29; 176(2):406-10. PubMed ID: 6208057
    [Abstract] [Full Text] [Related]

  • 3. Proceedings: Elongation factor 2: amino acid sequence at the site of ADP-ribosylation.
    Maxwell ES, Robinson EA, Henriksen O.
    J Biochem; 1975 Jan 01; 77(1?):9p-b. PubMed ID: 1137991
    [No Abstract] [Full Text] [Related]

  • 4. Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties.
    Bodley JW, Dunlop PC, VanNess BG.
    Methods Enzymol; 1984 Jan 01; 106():378-87. PubMed ID: 6387379
    [No Abstract] [Full Text] [Related]

  • 5. Endogenous ADP-ribosylation of elongation factor 2 in polyribosome fraction of rabbit reticulocytes.
    Sitikov AS, Davydova EK, Ovchinnikov LP.
    FEBS Lett; 1984 Oct 15; 176(1):261-3. PubMed ID: 6092136
    [Abstract] [Full Text] [Related]

  • 6. Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2.
    Oppenheimer NJ, Bodley JW.
    J Biol Chem; 1981 Aug 25; 256(16):8579-81. PubMed ID: 6267047
    [Abstract] [Full Text] [Related]

  • 7. [The eukaryotic elongation factor EF-2 loses its nonspecific affinity for RNA as a result of ADP ribosylation].
    Bezlepkina TA, Davydova EK, Sitikov AS, Vertiev IuA, Ezepchuk IuV.
    Dokl Akad Nauk SSSR; 1984 Aug 25; 278(3):751-4. PubMed ID: 6209075
    [No Abstract] [Full Text] [Related]

  • 8. Primary structure of elongation factor 2 around the site of ADP-ribosylation is highly conserved from archaebacteria to eukaryotes.
    Gehrmann R, Henschen A, Klink F.
    FEBS Lett; 1985 Jun 03; 185(1):37-42. PubMed ID: 3996598
    [Abstract] [Full Text] [Related]

  • 9. Reduced ribosomal binding of eukaryotic elongation factor 2 following ADP-ribosylation. Difference in binding selectivity between polyribosomes and reconstituted monoribosomes.
    Nygård O, Nilsson L.
    Biochim Biophys Acta; 1985 Feb 20; 824(2):152-62. PubMed ID: 3970930
    [Abstract] [Full Text] [Related]

  • 10. ADP-ribosylation.
    Ueda K, Hayaishi O.
    Annu Rev Biochem; 1985 Feb 20; 54():73-100. PubMed ID: 3927821
    [No Abstract] [Full Text] [Related]

  • 11. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y, Harashima S, Kohno K.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1145-51. PubMed ID: 8466491
    [Abstract] [Full Text] [Related]

  • 12. ADP-ribosylation of elongation factor 2 by diphtheria toxin. Isolation and properties of the novel ribosyl-amino acid and its hydrolysis products.
    Van Ness BG, Howard JB, Bodley JW.
    J Biol Chem; 1980 Nov 25; 255(22):10717-20. PubMed ID: 7000782
    [Abstract] [Full Text] [Related]

  • 13. 1-N6-Etheno-ADP-ribosylation of elongation factor-2 by diphtheria toxin.
    Giovane A, Balestrieri C, Quagliuolo L, Servillo L.
    FEBS Lett; 1985 Oct 28; 191(2):191-4. PubMed ID: 2996930
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the endogenous ADP-ribosylation of wild-type and mutant elongation factor 2 in eukaryotic cells.
    Fendrick JL, Iglewski WJ, Moehring JM, Moehring TJ.
    Eur J Biochem; 1992 Apr 01; 205(1):25-31. PubMed ID: 1313365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M, Nurten R, Ergen K, Bermek E.
    Cell Biochem Funct; 2006 Apr 01; 24(4):369-80. PubMed ID: 16142694
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Active-site mutations of the diphtheria toxin catalytic domain: role of histidine-21 in nicotinamide adenine dinucleotide binding and ADP-ribosylation of elongation factor 2.
    Blanke SR, Huang K, Wilson BA, Papini E, Covacci A, Collier RJ.
    Biochemistry; 1994 May 03; 33(17):5155-61. PubMed ID: 8172890
    [Abstract] [Full Text] [Related]

  • 19. On the mode of inhibition of eukaryotic protein synthesis by ADP-ribosylation of elongation factor 2.
    Nurten R, Albeniz I, Bermek E.
    IUBMB Life; 1999 Nov 03; 48(5):557-62. PubMed ID: 10637774
    [Abstract] [Full Text] [Related]

  • 20. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K, Bektaş M, Gökçe S, Nurten R.
    Biocell; 2007 Nov 03; 31(1):61-6. PubMed ID: 17665640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.